Ignite Creation Date:
2024-05-05 @ 6:35 PM
Last Modification Date:
2024-10-26 @ 9:34 AM
Study NCT ID:
NCT00504920
Status:
COMPLETED
Last Update Posted:
2012-08-01
First Post:
2007-07-18
Brief Title:
Symptom-Related Cytokines in Acute Myeloblastic Leukemia and Myelodysplastic Syndrome Patients
Sponsor:
Organization:
MD Anderson Cancer Center
Study Design
Study Type:
OBSERVATIONAL
Expanded Access Type Individual:
None
Expanded Access Type Intermediate:
None
Expanded Access Type Treatment:
None
Patient Registry:
None
Target Duration:
None
Design Allocation:
Design Intervention Model:
Design Intervention Model Description:
Design Masking Description:
Bio Spec Retention:
SAMPLES_WITH_DNA
Bio Spec Description:
At admission blood sample drawn around 2½ tablespoons to measure levels of cytokines before transplant procedure then another three days postadmission on day of transplant 1 day after transplant 3 days 8 days 15 days 22 days 29 days postransplant then between 50 - 60 days postransplant and again 80 - 100 days after transplant
Enrollment Count:
30
Enrollment Type:
ACTUAL
Design Primary Purpose:
Design Masking:
Phases:
Observational Models:
| Name |
|---|
| Case-Only |
Time Perspective List:
Clinical Trial Statuses
| Name |
|---|
| 3654 |
Who Masked List: